Skip to content

Tissue Bank for Pulmonary Diseases

Tissue Bank for Pulmonary Diseases

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00546962
Enrollment
400
Registered
2007-10-19
Start date
1999-04-01
Completion date
2022-12-01
Last updated
2026-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis

Brief summary

The aim of this research study is to collect and store the specimens that are left over after patients undergo tests ordered by their physicians. These specimens will be used at a later time by researchers in the Pulmonary Division to develop a better understanding of pulmonary diseases or for the development of new treatments. Typical research studies that will be conducted on the stored tissue, fluid, or bacteria from the patient sample involve obtaining bacterial cultures, measurement of inflammatory markers, and examination of the characteristics of the tissue. Other similar tests may be done in the future; however, these tests have not all been determined at this time. It is important to note that no genetic testing will be performed on any samples that are obtained as part of this protocol.

Interventions

None listed

Sponsors

Boston Children's Hospital
Lead SponsorOTHER
Harvard Medical School (HMS and HSDM)
CollaboratorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Open

Design outcomes

Primary

MeasureTime frameDescription
Tissue BankSingle baseline visit for each subject, study ended in October 2023Tissue Bank

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORThomas Martin, MD

Boston Children's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 28, 2026